AURELI, MASSIMO
 Distribuzione geografica
Continente #
EU - Europa 9.048
AS - Asia 8.536
NA - Nord America 8.228
SA - Sud America 699
AF - Africa 167
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 7
Totale 26.726
Nazione #
US - Stati Uniti d'America 7.981
CN - Cina 2.687
GB - Regno Unito 2.521
SG - Singapore 2.268
IT - Italia 2.188
DE - Germania 1.172
HK - Hong Kong 772
SE - Svezia 718
VN - Vietnam 661
BD - Bangladesh 629
RU - Federazione Russa 618
BR - Brasile 499
IN - India 460
NL - Olanda 338
FR - Francia 330
TR - Turchia 288
UA - Ucraina 214
KR - Corea 206
JP - Giappone 200
FI - Finlandia 185
IE - Irlanda 185
CA - Canada 141
PL - Polonia 140
ID - Indonesia 109
DK - Danimarca 104
EU - Europa 86
CO - Colombia 82
CI - Costa d'Avorio 58
BE - Belgio 57
GR - Grecia 52
AR - Argentina 51
MX - Messico 50
ES - Italia 42
AU - Australia 38
CH - Svizzera 38
AT - Austria 35
IQ - Iraq 35
ZA - Sudafrica 30
CZ - Repubblica Ceca 25
EC - Ecuador 24
IR - Iran 23
PK - Pakistan 21
PH - Filippine 18
TW - Taiwan 18
UZ - Uzbekistan 17
RO - Romania 15
VE - Venezuela 15
EG - Egitto 14
KE - Kenya 14
TH - Thailandia 14
CL - Cile 12
JM - Giamaica 11
SA - Arabia Saudita 11
SC - Seychelles 11
IL - Israele 10
JO - Giordania 10
PT - Portogallo 10
CR - Costa Rica 9
HR - Croazia 9
LU - Lussemburgo 9
MA - Marocco 9
NP - Nepal 9
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
LB - Libano 8
KG - Kirghizistan 7
MY - Malesia 7
RS - Serbia 7
TN - Tunisia 7
TT - Trinidad e Tobago 7
BO - Bolivia 6
SK - Slovacchia (Repubblica Slovacca) 6
DZ - Algeria 5
HN - Honduras 5
KZ - Kazakistan 5
LT - Lituania 5
NO - Norvegia 5
SN - Senegal 5
AL - Albania 4
BH - Bahrain 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
NI - Nicaragua 4
PE - Perù 4
SI - Slovenia 4
LK - Sri Lanka 3
MU - Mauritius 3
OM - Oman 3
PA - Panama 3
PY - Paraguay 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
AM - Armenia 2
BB - Barbados 2
BG - Bulgaria 2
CY - Cipro 2
EE - Estonia 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
MO - Macao, regione amministrativa speciale della Cina 2
Totale 26.772
Città #
Southend 2.221
Singapore 1.256
Milan 1.024
Ashburn 958
Hong Kong 676
Dallas 588
San Jose 513
Beijing 508
Chandler 477
Santa Clara 307
Frankfurt am Main 297
Los Angeles 262
Princeton 250
Council Bluffs 242
Hanover 242
Ann Arbor 241
New York 218
Wilmington 214
Seattle 207
Hefei 206
Fairfield 201
Ho Chi Minh City 194
Hanoi 186
Dublin 184
Boardman 162
Bengaluru 155
Jacksonville 148
Dearborn 123
Lauterbourg 121
Guangzhou 113
Warsaw 112
Nanjing 109
Woodbridge 107
Shanghai 104
Moscow 103
Buffalo 97
Redmond 96
Tokyo 88
Des Moines 87
Houston 86
Cambridge 79
Somerville 76
Mountain View 73
Helsinki 72
Jakarta 71
Rome 70
Sakarya 63
Serra 63
Bogotá 62
Redwood City 61
Istanbul 60
Naples 59
Abidjan 58
Columbus 57
Munich 57
Tianjin 56
Cangzhou 54
Phoenix 54
Brussels 53
Andover 52
Ponte San Pietro 52
Seoul 51
The Dalles 48
Changsha 47
Jinan 46
São Paulo 46
Berlin 45
Toronto 43
Menlo Park 40
Nanchang 40
Athens 39
Medford 39
Shenyang 39
Fuzhou 36
Hangzhou 33
Da Nang 32
Nuremberg 32
London 31
Chicago 28
Bitonto 27
Genoa 27
Limbiate 27
Turin 27
Amsterdam 26
Montreal 25
Zhengzhou 25
Mumbai 24
Stockholm 24
Varedo 24
Wuhan 24
Chengdu 23
Washington 22
Atlanta 21
Hebei 21
Bari 20
Grafing 20
Haiphong 20
Jiaxing 20
Quanzhou 20
San Diego 20
Totale 15.987
Nome #
HEBE project: Healthy aging versus inflamm-aging: The role of physical exercise in modulating the biomarkers of age-associated and environmentally determined chronic diseases, study protocol 691
Role of sialidase Neu3 and ganglioside GM3 in cardiac fibroblasts activation 617
Phages as immunomodulators and their promising use as anti-inflammatory agents in a cftr loss-of-function zebrafish model 422
Malignant phenotype of renal cell carcinoma cells is switched by Ukrain administration in vitro 410
Mitochondrial Dysregulation and Impaired Autophagy in iPSC-Derived Dopaminergic Neurons of Multiple System Atrophy 353
Role of gangliosides and Plasma Membrane-Associated Sialidase in the Process of Cell Membrane Organization 344
A novel homozygous VPS11 variant may cause generalized dystonia 336
Plasma membrane associated enzymes for sphingolipid structural changes and neuronal development 319
Exploring the effect of chirality on the therapeutic potential of N-alkyl-deoxyiminosugars: anti-inflammatory response to Pseudomonas aeruginosa infections for application in CF lung disease 311
Evidence for the involvement of lipid rafts and plasma membrane sphingolipid hydrolases in pseudomonas aeruginosa infection of cystic fibrosis bronchial epithelial cells 309
Animal Models to Translate Phage Therapy to Human Medicine 308
Crosstalk between sphingosine-1-phosphate and EGFR signalling pathways enhances human glioblastoma cell invasiveness 298
Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism 298
APOL1 polymorphism modulates sphingolipid profile of human podocytes 295
Sphingolipids role in the regulation of inflammatory response: From leukocyte biology to bacterial infection 294
A lysosome-plasma membrane-sphingolipid axis linking lysosomal storage to cell growth arrest 291
The GBAP1 pseudogene acts as a ceRNA for the glucocerebrosidase gene GBA by sponging miR-22-3p 288
Aberrant Glycosphingolipid Expression and Mambrane Organization in Tumor Cells : Consequences on Tumor-Host Interactions 265
Induction of axonal differentiation by silencing plasma membrane associated sialidase Neu3 in neuroblastoma cells 261
GM1 oligosaccharide efficacy against α-synuclein aggregation and toxicity in vitro 259
Biochemical Characterization of the GBA2 c.1780G>C Missense Mutation in Lymphoblastoid Cells from Patients with Spastic Ataxia 258
Novel bicistronic lentiviral vectors correct beta-Hexosaminidase deficiency in neural and hematopoietic stem cells and progeny: implications for in vivo and ex vivo gene therapy of GM2 gangliosidosis 256
Role of Lysosomal Gene Variants in Modulating GBA-Associated Parkinson's Disease Risk 250
Sphingosine kinase mediates resistance to the synthetic retinoid N-(4-hydroxyphenyl)retinamide in human ovarian cancer cells 247
Ceramide production at the plasma membrane from glycosphingolipid 246
A glycosphingolipid/caveolin-1 Signaling Complex Inhibits Motility of Human Ovarian Carcinoma Cells 245
Deregulated sphingolipid metabolism and membrane organization in neurodegenerative disorders 243
Increased extracellular matrix remodeling is induced in astrocytes by glioma/astrocytes interaction in a co-culture experimental model 237
Sphingosine-1-P and its plasma membrane receptors in human glioma cells 236
Evaluation of phages and liposomes as combination therapy to counteract Pseudomonas aeruginosa infection in wild-type and CFTR-null models 235
Activity of plasma membrane β-galactosidase and β-glucosidase 235
β-Glucocerebrosidase Deficiency Activates an Aberrant Lysosome-Plasma Membrane Axis Responsible for the Onset of Neurodegeneration 235
Neoglycoconjugates Derived from Deoxynojirimycin as Possible Therapeutic Agents for Cystic Fibrosis Lung Disease, by Modulation of the Sphingolipid Metabolism 234
Lewy pathology formation in patient-derived GBA1 Parkinson's disease midbrain organoids 228
Aberrant glycosphingolipid expression and membrane organization in tumor cells : consequences on tumor-host interactions 226
Massive Accumulation of Sphingomyelin Affects the Lysosomal and Mitochondria Compartments and Promotes Apoptosis in Niemann-Pick Disease Type A 222
Current and novel aspects on the non-lysosomal β-Glucosylceramidase GBA2 219
Induction of Axonal Differentiation by Silencing Plasma Membrane Associated Sialidase Neu3 in Neuroblastoma Cells 217
Ceramide production at the plasma membrane 216
GM1 Oligosaccharide Efficacy in Parkinson’s Disease: Protection against MPTP 215
Altered glycosphingolipid metabolism and membrane organization in fenretinide-resistant human ovarian carcinoma cells 215
Crosstalk between S1P and EGFR signalling pathways in human glioma cell invasiveness 214
Gangliosides and Cell Surface Ganglioside Metabolic Enzymes in the Nervous System 213
A Glycosphingolipid/caveolin-1 signaling complex inhibits the motility of human ovarian carcinoma cells 213
Induction of axonal differentiation by silencing plasma membrane asoociatyed sialidase Neu3 in neuroblastoma cells 212
Glycosphingolipids 212
Altered Glycosfhingolipid Metabolism and Membrane Organization in Fenretinide-Resistant Human ovarian carcinoma Cells 210
Glycosynapses : membrane organization and its role in defining the properties of tumor cells 206
Sphingolipids as modulators of membrane signaling complex 206
GM1 neurotrophic properties are related to GM1 oligosaccharide - TRKA interaction. 206
Plasma membrane associated enzymes for sphingolipid structural changes and neuronal development 205
Sphingolipids and plasma membrane hydrolases in human primary bronchial cells during differentiation and their altered patterns in cystic fibrosis 203
SARS-CoV-2 hampers dopamine production in iPSC-derived dopaminergic neurons 201
Turning the spotlight on the oligosaccharide chain of GM1 ganglioside 200
GM3 synthase overexpression results in reduced cell motility and caveolin-1 up-regulation in human ovarian carcinoma cells 200
Metabolic Profile Variations along the Differentiation of Human-Induced Pluripotent Stem Cells to Dopaminergic Neurons 197
Differentiation of mouse neuroblastoma cells induced by short hairpin RNA transfection of plasma membrane sialidase Neu 3 197
Cell surface sphingolipid glycohydrolase un neronal differentiation and aging in culture 195
Cell surface associated glycohydrolases in normal and Gaucher disease fibroblasts 193
Role of gangliosides and of plasma membrane associated sialidase in the process of cell membrane organization and cell functions 192
Plasma membrane-associated glycohydrolases activation by extracellular acidification due to proton exchangers 192
GBA2-encoded β-glucosidase activity is involved in the inflammatory response to Pseudomonas aeruginosa 192
Induction of Axonal Differentiation By Silencing Plasma membrane Associated Sialidase Neu3 in Neuroblastoma Cells 190
Altered sphingolipid metabolism and membrane organisation are associated with reduced invasivity in HPR-resistant human ovarian carcinoma cells 189
The role of 3-O-sulfogalactosylceramide, sulfatide, in the lateral organization of myelin membrane 189
Cell surface glycohydrolase modulation during tumor irradiation 188
Gangliosides and cell surface ganglioside glycohydrolases in the nervous system 188
Altered sphingolipid metabolism and membrane organisation are associated with reduced invasivity in HPR-resistant human ovarian carcinoma cells 187
What the cell surface does not see: the gene vector under the protein corona 185
Induction of Axonal Differentiation- by Silencing Plasma Membrane Associated Sialidase Neu3 in Neuroblastoma cells 183
GM1 structural requirements to mediate neuronal functions 182
Sphingolipid photoactivable metabolic precursors allow identification of specific sphingomyelin protein environment in lipid membrane domains of living c 182
Sphingolipids as modulators of membrane signalling complexes 181
Glycosphingolipid patterns and glycohydrolases behavior in acid-sphingomyelinase knock-out mice 181
Sphingosine-1 phosphate mediates proliferation and resistance to HPR in human ovarian carcinoma cells 180
The galactocerebrosidase enzyme contributes to maintain a functional neurogenic niche during early post-natal CNS development 180
Study of the neurodifferentiative role of GM1 oligosaccharide chain in mouse primary cerebellar neurons 178
Sphingolipidomics af A2780 human ovarian carcinoma cells treated with synthetic retinoids 176
The Glycosphingolipid Hydrolases in the Central Nervous System 175
Tezacaftor is a direct inhibitor of sphingolipid delta-4 desaturase enzyme (DEGS) 172
Metabolic labeling of cell sphingolipids : biosynthesis of photoactivable radioactive sphingomyelin and its interaction with cell proteins 171
Lipid Rafts in Neurodegeneration and Neuroprotection 171
Exploring the link between ceramide and ionizing radiation 170
Cross‐talk between CFTR and sphingolipids in cystic fibrosis 169
GM3 synthase regulates caveolin-1 expression and cell motility in human ovarian carcinoma cells 169
Altered Glycosphigolipid Methabolism and Membrane Organization in Feritinide-Resistant Human Ovarian Carcinoma Cells 169
Anti-inflammatory activity of Pseudomonas aeruginosa DEV phage in cystic fibrosis models 168
Interactions between gangliosides and proteins in the exoplasmic leaflet of neuronal plasma membranes: a study performed with a tritium labelled GM1 derivative containing a photoactivable group linked to the oligosaccharide chain 168
Lipid membrane domains in the brain 166
The motility of ovarian carcinoma cells in reguleted through a glycosphingolipid/Caveolin-1 signaling complex 165
Metabolic and Structural Consequences of GM3 Synthase Deficiency: Insights from an HEK293-T Knockout Model 163
Ceramide production at the plasma membrane from glycosphingolipid 163
Methods for the study of sphingolipid-protein interactions at the level of plasma membrane lipid domains 162
Photoactivable sphingosine as a tool to study membrane microenviroments in cultured cells 162
ASAH1 variant causing a mild SMA phenotype with no myoclonic epilepsy : a clinical, biochemical and molecular study 161
Unravelling the role of sphingolipids in cystic fibrosis lung disease 161
Neuronal membrane dynamics as fine regulator of sphingolipid composition 159
Abiraterone and ionizing radiation alter the sphingolipid homeostasis in prostate cancer cells 156
In situ metabolic synthesis of photoactivable sphingolipids in cultured cells : applications to the study of interactions between sphingolipids and plasma membrane proteins 155
Altered Glycosphingolipid Metabolism and Membrane Organization in Fenretinide-Resistant Human Ovarian Carcinoma Cells 153
Totale 22.710
Categoria #
all - tutte 75.169
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.169


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.954 187 70 92 146 211 111 135 126 218 191 149 318
2022/20232.043 254 219 167 206 228 371 77 130 209 36 108 38
2023/20241.796 55 96 93 204 486 72 105 113 31 102 232 207
2024/20254.279 190 425 140 390 310 197 158 401 338 487 405 838
2025/20269.543 984 712 1.185 717 736 511 1.189 369 821 616 960 743
2026/2027149 149 0 0 0 0 0 0 0 0 0 0 0
Totale 27.921